$ASNS
ACTELIS NETWORKS INC Stock $asns

$asns Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000121390024043030 Filed on May 14, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q1
Revenue	$3.431M	$726.0K	$1.848M
YoY Change	80.96%	-60.71%	-1.18%
Cost Of Revenue	$1.488M	$506.0K	$1.160M
YoY Change	17.72%	-56.38%	-10.08%
Gross Profit	$1.943M	$220.0K	$688.0K
YoY Change	207.44%	-68.02%	18.21%
Gross Profit Margin	56.63%	30.3%	37.23%
Selling, General & Admin	$1.437M	$1.444M	$1.794M
YoY Change	-14.52%	-19.51%	31.91%
% of Gross Profit	73.96%	656.36%	260.76%
Research & Development	$603.0K	$647.0K	$757.0K
YoY Change	-9.87%	-14.53%	16.46%
% of Gross Profit	31.03%	294.09%	110.03%
Depreciation & Amortization	$4.000K	$4.000K	$7.000K
YoY Change	-33.33%	-42.86%	-450.0%
% of Gross Profit	0.21%	1.82%	1.02%
Operating Expenses	$1.877M	$2.091M	$2.551M
YoY Change	-20.13%	-18.03%	20.5%
Operating Profit	$66.00K	-$1.871M	-$1.863M
YoY Change	-103.84%	0.43%	21.37%
Interest Expense	-$144.0K	-$61.00K	$180.0K
YoY Change	-184.21%	-133.89%	68.22%
% of Operating Profit	-218.18%
Other Income/Expense, Net		$92.00K	$148.0K
YoY Change		-37.84%	-104.61%
Pretax Income	-$78.00K	-$1.986M	-$1.895M
YoY Change	-95.1%	4.8%	-59.16%
Income Tax
% Of Pretax Income
Net Earnings	-$78.00K	-$1.986M	-$1.895M
YoY Change	-95.1%	4.8%	-59.15%
Net Earnings / Revenue	-2.27%	-273.55%	-102.54%
Basic Earnings Per Share	-$0.01	-$0.50	-$1.09
Diluted Earnings Per Share	-$0.01	-$0.50	-$1.09
COMMON SHARES
Basic Shares Outstanding	3.354M shares	3.020M shares	17.41M shares
Diluted Shares Outstanding	4.258M shares	3.979M shares	1.734M shares

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.412M	$1.408M	$1.618M
YoY Change	-28.68%	-12.98%	167.0%
Cash & Equivalents	$2.412M	$1.211M	$808.0K
Short-Term Investments	$0.00	$197.0K	$810.0K
Other Short-Term Assets	$1.281M	$1.641M	$1.193M
YoY Change	38.64%	37.55%	14.16%
Inventory	$2.158M	$2.608M	$1.274M
Prepaid Expenses
Receivables	$690.0K	$533.0K	$2.473M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$6.541M	$6.190M	$6.558M
YoY Change	-16.92%	-5.61%	67.3%
LONG-TERM ASSETS
Property, Plant & Equipment	$55.00K	$58.00K	$76.00K
YoY Change	-21.43%	-23.68%	-92.21%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.761M	$4.268M	$5.367M
YoY Change	-68.73%	-20.48%	1130.96%
Total Long-Term Assets	$1.816M	$4.326M	$5.443M
YoY Change	-68.15%	-20.52%	286.03%
TOTAL ASSETS
Total Short-Term Assets	$6.541M	$6.190M	$6.558M
Total Long-Term Assets	$1.816M	$4.326M	$5.443M
Total Assets	$8.357M	$10.52M	$12.00M
YoY Change	-38.43%	-12.37%	125.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.421M	$2.258M	$1.400M
YoY Change	-25.91%	61.29%	-9.09%
Accrued Expenses	$2.557M	$2.667M	$2.389M
YoY Change	11.08%	11.64%	-7.76%
Deferred Revenue	$206.0K
YoY Change
Short-Term Debt	$1.045M	$574.0K	$0.00
YoY Change
Long-Term Debt Due	$460.0K	$1.088M	$1.206M
YoY Change	-62.39%	-9.78%	-83.41%
Total Short-Term Liabilities	$6.471M	$8.890M	$6.372M
YoY Change	-3.65%	39.52%	-47.73%
LONG-TERM LIABILITIES
Long-Term Debt	$263.0K	$2.521M	$3.712M
YoY Change	-92.39%	-32.09%	-54.06%
Other Long-Term Liabilities	$27.00K	$23.00K	$33.00K
YoY Change	-15.63%	-30.3%	-100.4%
Total Long-Term Liabilities	$749.0K	$3.135M	$4.214M
YoY Change	-86.3%	-25.61%	-4782.22%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.471M	$8.890M	$6.372M
Total Long-Term Liabilities	$749.0K	$3.135M	$4.214M
Total Liabilities	$7.220M	$12.03M	$10.59M
YoY Change	-40.75%	13.59%	-55.82%
SHAREHOLDERS EQUITY
Retained Earnings	-$41.75M	-$41.67M	-$35.30M
YoY Change	13.18%	18.07%
Common Stock	$1.000K	$1.000K	$1.000K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$936.0K	-$1.668M	$1.415M
YoY Change
Total Liabilities & Shareholders Equity	$8.357M	$10.52M	$12.00M
YoY Change	-38.43%	-12.37%	125.16%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	-$78.00K	-$1.986M	-$1.895M
YoY Change	-95.1%	4.8%	-59.15%
Depreciation, Depletion And Amortization	$4.000K	$4.000K	$7.000K
YoY Change	-33.33%	-42.86%	-450.0%
Cash From Operating Activities	-$2.140M	-$203.0K	-$1.705M
YoY Change	73.42%	-88.09%	238.29%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$1.000K	$3.000K
YoY Change		-66.67%	-123.08%
Acquisitions
YoY Change
Other Investing Activities	$198.0K	$0.00	-$331.0K
YoY Change	-80.42%	-100.0%	26.34%
Cash From Investing Activities	$198.0K	-$1.000K	-$334.0K
YoY Change	-80.42%	-99.7%	21.45%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net		$193.0K	$192.0K
YoY Change		0.52%	48.84%
Cash From Financing Activities	167.0K	-$164.0K	-$242.0K
YoY Change	-94.47%	-32.23%	-11.03%
NET CHANGE
Cash From Operating Activities	-2.140M	-$203.0K	-$1.705M
Cash From Investing Activities	198.0K	-$1.000K	-$334.0K
Cash From Financing Activities	167.0K	-$164.0K	-$242.0K
Net Change In Cash	-1.775M	-$370.0K	-$2.281M
YoY Change	-163.42%	-83.78%	117.03%
FREE CASH FLOW
Cash From Operating Activities	-$2.140M	-$203.0K	-$1.705M
Capital Expenditures	$0.00	$1.000K	$3.000K
Free Cash Flow	-$2.140M	-$204.0K	-$1.708M
YoY Change	73.42%	-88.06%	247.86%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3978828	shares
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.50
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1734160	shares
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	001-41375
CY2024Q1	dei	Entity Registrant Name EntityRegistrantName	ACTELIS NETWORKS, INC.
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	52-2160309
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	4039 Clipper Court
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Fremont
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94538
CY2024Q1	dei	City Area Code CityAreaCode	(510)
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	545-1045
CY2024Q1	dei	Security12b Title Security12bTitle	Common Stock, $0.0001 par value per share
CY2024Q1	dei	Trading Symbol TradingSymbol	ASNS
CY2024Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2024Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	3354455	shares
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1211000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	620000	usd
CY2024Q1	us-gaap	Restricted Cash Equivalents Current RestrictedCashEquivalentsCurrent	1392000	usd
CY2023Q4	us-gaap	Restricted Cash Equivalents Current RestrictedCashEquivalentsCurrent	1565000	usd
CY2024Q1	us-gaap	Short Term Investments ShortTermInvestments	197000	usd
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	197000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	168000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	168000	usd
CY2024Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	533000	usd
CY2023Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	664000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	2608000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	2526000	usd
CY2024Q1	asns	Allowance For Doubtful Debts Prepaid Expenses AllowanceForDoubtfulDebtsPrepaidExpenses	181000	usd
CY2023Q4	asns	Allowance For Doubtful Debts Prepaid Expenses AllowanceForDoubtfulDebtsPrepaidExpenses	144000	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	249000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	340000	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	6190000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	5912000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	58000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	61000	usd
CY2024Q1	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	592000	usd
CY2023Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	592000	usd
CY2024Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	2542000	usd
CY2023Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	3330000	usd
CY2024Q1	asns	Restricted Bank Deposits Noncurrent RestrictedBankDepositsNoncurrent	90000	usd
CY2023Q4	asns	Restricted Bank Deposits Noncurrent RestrictedBankDepositsNoncurrent	94000	usd
CY2024Q1	asns	Severance Pay Fund Noncurrent SeverancePayFundNoncurrent	238000	usd
CY2023Q4	asns	Severance Pay Fund Noncurrent SeverancePayFundNoncurrent	238000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	728000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	918000	usd
CY2024Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	78000	usd
CY2023Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	78000	usd
CY2024Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	4326000	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	5311000	usd
CY2024Q1	us-gaap	Assets Assets	10516000	usd
CY2023Q4	us-gaap	Assets Assets	11223000	usd
CY2024Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	574000	usd
CY2024Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	1088000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1335000	usd
CY2024Q1	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	2258000	usd
CY2023Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	1769000	usd
CY2024Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	305000	usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	389000	usd
CY2024Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	855000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	737000	usd
CY2024Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1143000	usd
CY2024Q1	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	1087000	usd
CY2023Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	1062000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	465000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	498000	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1115000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1122000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	8890000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6912000	usd
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2521000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	3154000	usd
CY2024Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	68000	usd
CY2023Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	71000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	254000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	405000	usd
CY2024Q1	asns	Accrued Severance Noncurrent AccruedSeveranceNoncurrent	269000	usd
CY2023Q4	asns	Accrued Severance Noncurrent AccruedSeveranceNoncurrent	270000	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	23000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	23000	usd
CY2024Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	3135000	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	3923000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	12025000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	10835000	usd
CY2024Q1	asns	Warrants To Placement Agent WarrantsToPlacementAgent	159000	usd
CY2023Q4	asns	Warrants To Placement Agent WarrantsToPlacementAgent	159000	usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3010244	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3010244	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3007745	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3007745	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	1000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	1000	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	40005000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	39916000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-41674000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-39688000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-1668000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	229000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	10516000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	11223000	usd
CY2024Q1	us-gaap	Revenues Revenues	726000	usd
CY2023Q1	us-gaap	Revenues Revenues	1848000	usd
CY2024Q1	us-gaap	Cost Of Revenue CostOfRevenue	506000	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	1160000	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	220000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	688000	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	647000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	757000	usd
CY2024Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	627000	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	929000	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	817000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	865000	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	2091000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	2551000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1871000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1863000	usd
CY2024Q1	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	207000	usd
CY2023Q1	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	180000	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	92000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	148000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-1986000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1895000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.5
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.09
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3978828	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1734160	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	3265000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	95000	usd
CY2023Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	50000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1895000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	1415000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	229000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	89000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-1986000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-1668000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-1986000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1895000	usd
CY2024Q1	us-gaap	Depreciation Depreciation	4000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	7000	usd
CY2023Q1	us-gaap	Inventory Write Down InventoryWriteDown	7000	usd
CY2024Q1	asns	Exchange Rate Difference ExchangeRateDifference	70000	usd
CY2023Q1	asns	Exchange Rate Difference ExchangeRateDifference	130000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	89000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	95000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	-61000	usd
CY2024Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	1000	usd
CY2023Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	51000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-131000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-561000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-6000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-16000	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	83000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	102000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-91000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-265000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	490000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-381000	usd
CY2024Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-87000	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-35000	usd
CY2024Q1	asns	Increase Decrease In Advances From Customers IncreaseDecreaseInAdvancesFromCustomers	1143000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	131000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-46000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-16000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-203000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1705000	usd
CY2023Q1	asns	Proceedsfrom Short Term Deposits ProceedsfromShortTermDeposits	812000	usd
CY2023Q1	asns	Restricted Short Term Bank Deposit RestrictedShortTermBankDeposit	329000	usd
CY2023Q1	us-gaap	Payments To Acquire Restricted Investments PaymentsToAcquireRestrictedInvestments	811000	usd
CY2023Q1	asns	Payments For Proceeds From Long Term Deposit PaymentsForProceedsFromLongTermDeposit	3000	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-334000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	50000	usd
CY2024Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	574000	usd
CY2024Q1	asns	Early Repayment Of Longterm Loan EarlyRepaymentOfLongtermLoan	545000	usd
CY2024Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	193000	usd
CY2023Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	192000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-164000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-242000	usd
CY2024Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-2000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-5000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-370000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2281000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5515000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4279000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5145000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1998000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1211000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	808000	usd
CY2024Q1	us-gaap	Restricted Cash Equivalents Current RestrictedCashEquivalentsCurrent	1392000	usd
CY2024Q1	us-gaap	Restricted Cash Equivalents Noncurrent RestrictedCashEquivalentsNoncurrent	2542000	usd
CY2023Q1	us-gaap	Restricted Cash Equivalents Noncurrent RestrictedCashEquivalentsNoncurrent	1190000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5145000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1998000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	273000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	116000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-1986000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1895000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-203000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1705000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-41674000	usd
CY2024Q1	us-gaap	Cash Cash	2800000	usd
CY2024Q1	us-gaap	Restricted Cash And Investments RestrictedCashAndInvestments	2632000	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top"> <td style="width: 0.5in"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use of estimates in preparation of financial statements </b></span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. The Company evaluates on an ongoing basis its assumptions, including those related to contingencies, fair values of financial instruments, inventory write-offs, as well as in estimates used in applying the revenue recognition policy. The Company’s management believes that the estimates, judgments, and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the unaudited condensed consolidated financial statements, and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates.</span></p>
CY2024Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	8000	usd
CY2023Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	8000	usd
CY2024Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Concentration of risk</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents, restricted cash and cash equivalents, and trade receivables. Cash and cash equivalents and restricted cash and cash equivalents are placed with banks and financial institutions in the United States and Israel.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management believes that the financial institutions that hold the Company’s investments are financially sound and, accordingly, present minimal credit risk with respect to those investments.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s trade receivables are derived primarily from telecommunication operators, the Company’s reseller customers and enterprises located mainly in the United States, Europe, and Asia.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Credit risk with respect to trade receivables exists to the full extent of the amounts presented in the consolidated financial statements. Management makes judgments as to its ability to collect outstanding accounts receivable and provides allowances for the applicable portion of accounts receivable when collection becomes doubtful.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management provides allowances based upon a specific review of all significant outstanding invoices, analysis of its historical collection experience, and current economic trends. If the historical data used to calculate the allowance for credit losses does not reflect the Company’s future ability to collect outstanding accounts receivable, additional provisions for credit losses may be needed, and the future results of operations could be materially affected.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has customers balances representing 10% or more of Trade receivables as follows:</span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.75in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer A represented 13% and 30% of the Company Trade receivables balance as of March 31, 2024, and December 31, 2023, respectively.</span></td> </tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.75in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer B represented 30% and 11% of the Company Trade receivables balance as of March 31, 2024, and December 31, 2023, respectively.</span></td> </tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.75in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer C represented 0% and 11% of the Company Trade receivables balance as of March 31, 2024, and December 31, 2023, respectively.</span></td> </tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.75in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer D represented 11% and 5% of the Company Trade receivables balance as of March 31, 2024, and December 31, 2023, respectively.</span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company does not see any credit risk regarding the major trade receivable balance.</span></p>
CY2024Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	737000	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	757000	usd
CY2024Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1871000	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1769000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	2608000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	2526000	usd
CY2023Q1	us-gaap	Inventory Write Down InventoryWriteDown	7000	usd
CY2020Q3	us-gaap	Amount Of Regulatory Assistance Received1 AmountOfRegulatoryAssistanceReceived1	150000	usd
CY2020Q4	us-gaap	Loans Payable LoansPayable	20000000	ils
CY2020Q4	us-gaap	Loans Payable LoansPayable	6000000	usd
CY2020Q4	us-gaap	Financing Receivable Loan In Process FinancingReceivableLoanInProcess	3000000	usd
CY2021Q1	asns	Additional Loan Value AdditionalLoanValue	2000000	usd
CY2021Q4	us-gaap	Investment Company Increase From Payment By Affiliate And Gain Loss From Investment In Violation InvestmentCompanyIncreaseFromPaymentByAffiliateAndGainLossFromInvestmentInViolation	1000000	usd
CY2024Q1	us-gaap	Warrant Down Round Feature Increase Decrease In Equity Amount1 WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount1	1800000	usd
CY2022Q4	us-gaap	Carrying Value Of Securities Sold Under Repurchase Agreements And Deposits Received For Securities Loaned CarryingValueOfSecuritiesSoldUnderRepurchaseAgreementsAndDepositsReceivedForSecuritiesLoaned	2000000	usd
CY2023Q4	us-gaap	Long Term Notes And Loans LongTermNotesAndLoans	2000000	usd
CY2024Q1	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	2000000	ils
CY2024Q1	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	550000000	usd
CY2024Q1	us-gaap	Long Term Debt Percentage Bearing Fixed Interest Rate LongTermDebtPercentageBearingFixedInterestRate	0.096	pure
CY2024Q1	us-gaap	Stock Issued1 StockIssued1	150000	usd
CY2024Q1	us-gaap	Line Of Credit Facility Current Borrowing Capacity LineOfCreditFacilityCurrentBorrowingCapacity	3459000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	7000	usd
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	4023000	ils
CY2021Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	1092000	usd
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	527000	ils
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	144000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	9000	usd
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	3069000	ils
CY2021Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	834000	usd
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	704000	ils
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	191000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	9000	usd
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	3069000	ils
CY2021Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	834000	usd
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	704000	ils
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	191000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	9000	usd
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	3069000	ils
CY2021Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	834000	usd
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	704000	ils
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	191000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	225000	usd
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	255000	ils
CY2021Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	69000	usd
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	59000	ils
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	16000	usd
CY2024Q1	asns	Long Term Debt Less Accumulated Interest LongTermDebtLessAccumulatedInterest	-111000	usd
CY2020Q4	asns	Long Term Debt Less Accumulated Interest LongTermDebtLessAccumulatedInterest	2741000	ils
CY2021Q1	asns	Long Term Debt Less Accumulated Interest LongTermDebtLessAccumulatedInterest	744000	usd
CY2021Q4	asns	Long Term Debt Less Accumulated Interest LongTermDebtLessAccumulatedInterest	711000	ils
CY2021Q4	asns	Long Term Debt Less Accumulated Interest LongTermDebtLessAccumulatedInterest	193000	usd
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	148000	usd
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	10744000	ils
CY2021Q1	us-gaap	Long Term Debt LongTermDebt	2919000	usd
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	1987000	ils
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	540000	usd
CY2024Q1	asns	Exchange Rate ExchangeRate	1
CY2024Q1	asns	Exchange Rate ExchangeRate	3.681
CY2024Q1	us-gaap	Line Of Credit Facility Interest Rate During Period LineOfCreditFacilityInterestRateDuringPeriod	0.055	pure
CY2024Q1	us-gaap	Line Of Credit Facility Interest Rate During Period LineOfCreditFacilityInterestRateDuringPeriod	0.30	pure
CY2024Q1	us-gaap	Credit Derivative Liquidation Proceeds Percentage CreditDerivativeLiquidationProceedsPercentage	1	pure
CY2024Q1	us-gaap	Billed Contract Receivables BilledContractReceivables	14300000	usd
CY2024Q1	us-gaap	Interest Receivable InterestReceivable	15775000	usd
CY2024Q1	us-gaap	Recorded Unconditional Purchase Obligation Amount Of Maturities And Sinking Fund Requirements RecordedUnconditionalPurchaseObligationAmountOfMaturitiesAndSinkingFundRequirements	10275000	usd
CY2024Q1	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	1087000	usd
CY2023Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	1062000	usd
CY2024Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1143000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	50000	usd
CY2023Q2	us-gaap	Debt Instrument Issued Principal DebtInstrumentIssuedPrincipal	3500000	usd
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	190000	shares
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q2	asns	Prefunded Warrants To Purchase Common Stock PrefundedWarrantsToPurchaseCommonStock	754670	shares
CY2023Q2	asns	Prefunded Warrants PrefundedWarrants	754670	shares
CY2023Q2	us-gaap	Warrant Exercise Price Decrease WarrantExercisePriceDecrease	0.0001
CY2023Q3	asns	Exercise Of Prefunded Warrant ExerciseOfPrefundedWarrant	754670	shares
CY2023Q3	asns	Exercise Price Of Prefunded Warrant ExercisePriceOfPrefundedWarrant	0.0755
CY2023Q2	asns	Payments To Underwriter PaymentsToUnderwriter	291000	usd
CY2023Q2	asns	Exercise Price Percentage ExercisePricePercentage	1.25	pure
CY2023Q4	asns	Prefunded Warrants To Purchase Common Stock PrefundedWarrantsToPurchaseCommonStock	970187	shares
CY2023Q4	asns	Prefunded Warrants PrefundedWarrants	970187	shares
CY2023Q4	asns	Exercise Price Of Prefunded Warrant ExercisePriceOfPrefundedWarrant	0.0001
CY2023Q4	asns	Payments To Underwriter PaymentsToUnderwriter	129000	usd
CY2023Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	88983	shares
CY2023Q4	asns	Exercise Price Percentage ExercisePricePercentage	1.25	pure
CY2023Q4	asns	Offering Share Price OfferingSharePrice	1.475
CY2023Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	230000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	87764	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.63
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y1M9D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	723	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	16.33
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	87041	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.53
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y9M21D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	79866	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.39
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y1M13D
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-1986000	usd
CY2024Q1	us-gaap	Common Stock Other Shares Outstanding CommonStockOtherSharesOutstanding	3008641	shares
CY2023Q1	us-gaap	Common Stock Other Shares Outstanding CommonStockOtherSharesOutstanding	1737986	shares
CY2024Q1	asns	Pre Funded Warrants To Purchase Common Shares PreFundedWarrantsToPurchaseCommonShares	970187	shares
CY2023Q1	asns	Repurchase Of Common Stock RepurchaseOfCommonStock	-3827000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3978828	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1734160	shares
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.5
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.09
CY2024Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	pure
CY2024Q1	us-gaap	Revenues Revenues	726000	usd
CY2023Q1	us-gaap	Revenues Revenues	1848000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	460000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	648000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	242000	usd
CY2023	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	544000	usd
CY2024Q1	asns	Contract With Customer Liability Additions ContractWithCustomerLiabilityAdditions	155000	usd
CY2023	asns	Contract With Customer Liability Additions ContractWithCustomerLiabilityAdditions	356000	usd
CY2024Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	373000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	460000	usd
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	373000	usd
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	us-gaap	Short Term Borrowings ShortTermBorrowings		usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2024Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
CY2024Q1	us-gaap	Inventory Write Down InventoryWriteDown		usd
CY2023Q1	us-gaap	Interest Expense InterestExpense		usd
CY2023Q1	asns	Increase Decrease In Advances From Customers IncreaseDecreaseInAdvancesFromCustomers		usd
CY2024Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities		usd
CY2024Q1	asns	Proceedsfrom Short Term Deposits ProceedsfromShortTermDeposits		usd
CY2024Q1	asns	Restricted Short Term Bank Deposit RestrictedShortTermBankDeposit		usd
CY2024Q1	us-gaap	Payments To Acquire Restricted Investments PaymentsToAcquireRestrictedInvestments		usd
CY2024Q1	asns	Payments For Proceeds From Long Term Deposit PaymentsForProceedsFromLongTermDeposit		usd
CY2024Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock		usd
CY2023Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit		usd
CY2023Q1	us-gaap	Restricted Cash Equivalents Current RestrictedCashEquivalentsCurrent		usd
CY2024Q1	us-gaap	Inventory Write Down InventoryWriteDown		usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2024Q1	asns	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Life Granted SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLifeGranted
CY2024Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2024Q1	asns	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Life Exercised SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLifeExercised
CY2024Q1	asns	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Life Forfeited SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLifeForfeited
CY2023Q1	asns	Pre Funded Warrants To Purchase Common Shares PreFundedWarrantsToPurchaseCommonShares		shares
CY2024Q1	asns	Repurchase Of Common Stock RepurchaseOfCommonStock		usd
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1734160	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3978828	shares
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.50
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.09
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001141284

Files In Submission

Name	View Source	Status
0001213900-24-043030-index-headers.html	Edgar Link	pending
0001213900-24-043030-index.html	Edgar Link	pending
0001213900-24-043030.txt	Edgar Link	pending
0001213900-24-043030-xbrl.zip	Edgar Link	pending
asns-20240331.xsd	Edgar Link	pending
ea0205455-10q_actelisnet.htm	Edgar Link	pending
ea0205455ex31-1_actelisnet.htm	Edgar Link	pending
ea0205455ex31-2_actelisnet.htm	Edgar Link	pending
ea0205455ex32-1_actelisnet.htm	Edgar Link	pending
ea0205455ex32-2_actelisnet.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
asns-20240331_def.xml	Edgar Link	unprocessable
asns-20240331_lab.xml	Edgar Link	unprocessable
asns-20240331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
ea0205455-10q_actelisnet_htm.xml	Edgar Link	completed
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
asns-20240331_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ASNS
ACTELIS NETWORKS INC Stock $asns

2024 Q2 Form 10-Q Financial Statement

#000121390024043030 Filed on May 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ASNS ACTELIS NETWORKS INC Stock $asns

2024 Q2 Form 10-Q Financial Statement

#000121390024043030 Filed on May 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ASNS
ACTELIS NETWORKS INC Stock $asns